메뉴 건너뛰기




Volumn 2, Issue 4, 2010, Pages 333-335

All people over 75 years with a five-year CVD risk of ≥15% should be treated with statins unless specifically contraindicated

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

EID: 79952277280     PISSN: 11726164     EISSN: 11726156     Source Type: Journal    
DOI: 10.1071/hc10333     Document Type: Article
Times cited : (2)

References (7)
  • 1
    • 61849099515 scopus 로고    scopus 로고
    • Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: Population based observational cohort study
    • 2009 January 13, jan08_2
    • De Ruijter W, Westendorp RGJ, Assendelft WJJ, et al. Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study. BMJ. 2009 January 13, 2009;338(jan08_2):a3083-.
    • (2009) BMJ , vol.338
    • de Ruijter, W.1    Westendorp, R.G.J.2    Assendelft, W.J.J.3
  • 2
    • 0037164314 scopus 로고    scopus 로고
    • Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial
    • Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. The Lancet. 2002;360(9346):1623-30.
    • (2002) The Lancet , vol.360 , Issue.9346 , pp. 1623-1630
    • Shepherd, J.1    Blauw, G.J.2    Murphy, M.B.3
  • 3
    • 34548035644 scopus 로고    scopus 로고
    • Preventive health care in elderly people needs rethinking
    • 2007 August 11
    • Mangin D, Sweeney K, Heath I. Preventive health care in elderly people needs rethinking. BMJ. 2007 August 11, 2007;335(7614):285-7.
    • (2007) BMJ , vol.335 , Issue.7614 , pp. 285-287
    • Mangin, D.1    Sweeney, K.2    Heath, I.3
  • 4
    • 77954179995 scopus 로고    scopus 로고
    • Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65 229 participants
    • June 28
    • Ray KK, Seshasai SRK, Erqou S, et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65 229 participants. Arch Intern Med. 2010 June 28;170(12):1024-31.
    • (2010) Arch Intern Med , vol.170 , pp. 12
    • Ray, K.K.1    Seshasai, S.R.K.2    Erqou, S.3
  • 5
    • 62849117734 scopus 로고    scopus 로고
    • Statin use and its association with musculoskeletal symptoms-a cross-sectional study in primary care settings
    • 2009 April 1
    • Mosshammer D, Lorenz G, Meznaric S, Schwarz J, Muche R, Morike K. Statin use and its association with musculoskeletal symptoms-a cross-sectional study in primary care settings. Fam Pract. 2009 April 1, 2009;26(2):88-95.
    • (2009) Fam Pract , vol.26 , Issue.2 , pp. 88-95
    • Mosshammer, D.1    Lorenz, G.2    Meznaric, S.3    Schwarz, J.4    Muche, R.5    Morike, K.6
  • 6
    • 27744586186 scopus 로고    scopus 로고
    • Health outcomes and polypharmacy in elderly individuals: An integrated literature review
    • Sep
    • Frazier S. Health outcomes and polypharmacy in elderly individuals: an integrated literature review. J Gerontol Nurs. 2005 Sep;31(9):4-11.
    • (2005) J Gerontol Nurs , vol.31 , pp. 9
    • Frazier, S.1
  • 7
    • 27744540114 scopus 로고    scopus 로고
    • Pharmacist response to alerts generated from medicaid pharmacy claims in a long-term care setting: Results from the North Carolina Polypharmacy Initiative
    • Sep
    • Trygstad TK, Christensen D, Garmise J, Sullivan R, Wegner S. Pharmacist response to alerts generated from medicaid pharmacy claims in a long-term care setting: results from the North Carolina Polypharmacy Initiative. J Manag Care Pharm. 2005 Sep;11(7):575-83.
    • (2005) J Manag Care Pharm , vol.11 , pp. 7
    • Trygstad, T.K.1    Christensen, D.2    Garmise, J.3    Sullivan, R.4    Wegner, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.